Current Gastroenterology Reports

, Volume 14, Issue 6, pp 473–479

Chronic Proton Pump Inihibitor Therapy and Calcium Metabolism

Stomach and Duodenum (J Pisegna, Section Editor)

DOI: 10.1007/s11894-012-0290-4

Cite this article as:
Yang, YX. Curr Gastroenterol Rep (2012) 14: 473. doi:10.1007/s11894-012-0290-4


Proton pump inhibitors (PPIs) have been widely used since their introduction in the late 1980s because they are highly effective for acid-related conditions. However, some recent epidemiological studies have suggested a positive association between PPI therapy and the risk of osteoporotic fractures. The potential mechanisms underlying this association may be related to the physiologic effects of chronic acid suppression on calcium metabolism. First, chronic hypergastrinemia induced by PPI therapy may lead to parathyroid hyperplasia, resulting in increased loss of calcium from the bone. Second, profound gastric acid suppression may reduce the bioavailability of calcium for intestinal absorption. I will review the published evidence regarding these potential links and discuss their clinical implications.


Proton pump inhibitorsHypergastrinemiaHyperparathyroidismCalcium absorptionOsteoporosisPPIs and calcium metabolismPPI-induced hypergastrinemiaParathyroid glandsBone metabolismCalcium balance

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Division of GastroenterologyThe Perelman School of Medicine at the University of PennsylvaniaPhiladelphiaUSA
  2. 2.Center for Clinical Epidemiology and Biostatistics, and Department of Biostatistics and EpidemiologyThe Perelman School of Medicine at the University of PennsylvaniaPhiladelphiaUSA